A Novel NGF Receptor Agonist B355252 Ameliorates Neuronal Loss and Inflammatory Responses in a Rat Model of Cerebral Ischemia.
Hao-Kuang WangJui-Sheng ChenChien-Yu HsuYu-Ting SuTzu-Ching SungCheng-Loong LiangAij-Lie KwanCheng-Chun WuPublished in: Journal of inflammation research (2021)
Overall, our study verified the in vivo therapeutic potential of B355252. The study findings further support its application in the development of a therapeutic approach for stroke.